載入...

Effects of RAF inhibitors on PI3K/AKT signalling depend on mutational status of the RAS/RAF signalling axis

Targeted therapies within the RAS/RAF/MEK/ERK signalling axis become increasingly popular, yet cross-talk and feedbacks in the signalling network lead to unexpected effects. Here we look systematically into how inhibiting RAF and MEK with clinically relevant inhibitors result in changes in PI3K/AKT...

全面介紹

Na minha lista:
書目詳細資料
發表在:Oncotarget
Main Authors: Fritsche-Guenther, Raphaela, Witzel, Franziska, Kempa, Stefan, Brummer, Tilman, Sers, Christine, Blüthgen, Nils
格式: Artigo
語言:Inglês
出版: Impact Journals LLC 2016
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4884967/
https://ncbi.nlm.nih.gov/pubmed/26799289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.6959
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!